These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3090486)

  • 21. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
    Morley PA; Munot LD
    Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonic acid: a new topical antimicrobial agent.
    Wuite J; Davies BI; Go M; Lambers J; Jackson D; Mellows G
    Lancet; 1983 Aug; 2(8346):394. PubMed ID: 6135884
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
    McLinn S
    Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with a new topical drug Rifoderm, a rifomycin-prednisolone ointment].
    Weitgasser H
    Wien Med Wochenschr; 1968 Dec; 118(51):1107-10. PubMed ID: 5729116
    [No Abstract]   [Full Text] [Related]  

  • 25. An intranasal irritation assessment of antibacterial ointment alone or in combination with mupirocin versus Bactroban Nasal in rabbits.
    Faqi AS; Bell SJ; Gill S; Colagiovanni DB
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):28-32. PubMed ID: 19497343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a broad-spectrum antibiotic (mupirocin) in an in vitro model of infected skin.
    Vizcaino-Alcaide MJ; Herruzo-Cabrera R; Rey-Calero J
    Burns; 1993 Oct; 19(5):392-5. PubMed ID: 8216765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonic acid, a new antibiotic for topical therapy.
    Wuite J; Davies BI; Go MJ; Lambers JC; Jackson D; Mellows G; Tasker TC
    J Am Acad Dermatol; 1985 Jun; 12(6):1026-31. PubMed ID: 3924981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with a new skin preparation in the dermatological practice].
    Pillau H
    Z Allgemeinmed; 1971 Nov; 47(33):1771-2. PubMed ID: 5131396
    [No Abstract]   [Full Text] [Related]  

  • 29. Mupirocin in a polyethylene glycol carrier base.
    Rode H; de Wet PM; Cywes S; Millar AJ
    J Antimicrob Chemother; 1989 Jul; 24(1):78-9. PubMed ID: 2506166
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sodium fucidin treatment of pustular skin diseases].
    Levkovskiĭ NM; Golovchenko DIa; Fedorenko AE
    Feldsher Akush; 1980; 45(11):21-2. PubMed ID: 6906270
    [No Abstract]   [Full Text] [Related]  

  • 31. Stability of mupirocin ointment (Bactroban) admixed with other proprietary dermatological products.
    Jagota NK; Stewart JT; Warren FW; John PM
    J Clin Pharm Ther; 1992 Jun; 17(3):181-4. PubMed ID: 1639880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic results with a new ointment foundation on basis of synthetic glycerides of saturated fatty acids].
    Schrümpf E
    Dermatol Wochenschr; 1966 Jun; 152(26):660-71. PubMed ID: 5963477
    [No Abstract]   [Full Text] [Related]  

  • 33. [Further studies in secondary infectious dermatoses with a combination of gentamycin and fluorinated corticoid in an ointment base (experiences with Decoderm)].
    Weitgasser H
    Landarzt; 1968 May; 44(13):662-4. PubMed ID: 5714221
    [No Abstract]   [Full Text] [Related]  

  • 34. Innovation and development in oral and topical antibiotics.
    Crook SJ
    Practitioner; 1986 Mar; 230(1413):249-56. PubMed ID: 3086858
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of mupirocin in cutaneous candidiasis.
    Rode H; de Wet PM; Millar AJ; Cywes S
    Lancet; 1991 Aug; 338(8766):578. PubMed ID: 1678836
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic effectiveness of an oxolinic ointment in certain viral dermatoses in children].
    Lipets ME
    Vestn Dermatol Venerol; 1975 Feb; (2):61-3. PubMed ID: 1154866
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureus.
    Kratzer C; Tobudic S; Macfelda K; Graninger W; Georgopoulos A
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3437-9. PubMed ID: 17620381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the prophylactic uses of topical mupirocin and nitrofurazone in murine crush contaminated wounds.
    Erdur B; Ersoy G; Yilmaz O; Ozkutuk A; Sis B; Karcioglu O; Parlak I; Ayrik C; Aksay E; Guryay M
    Am J Emerg Med; 2008 Feb; 26(2):137-43. PubMed ID: 18272091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A primer on topical antibiotics for the skin and eyes.
    Noah S
    J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.